GE HealthCare Technologies (GEHC) sees significant activity in its stock, with several companies increasing, decreasing, or initiating their shareholding. Focus Partners Wealth acquired an additional 50,272 shares, while USS Investment Management Ltd sold 14,700 shares. GEHC's stake has been increased by UBS AM with new stakes taken by Petrus Trust company, Dynamic Technology Lab, and others. The company has also gained a 'Moderate Buy' average rating from brokerages. GEHC has unveiled its most advanced AI-powered cardiovascular ultrasound system, Vivid Pioneer, indicating progress in its product portfolio. On the other hand, GEHC's stock has faced price depreciation, leading to some investors expressing concern. Notably, its Q2 earnings surpassed expectations, and the company has adjusted its annual profit forecast due to lower tariff impact. However, insiders disposing of stock has caused cautious sentiments in the market.
Ge Healthcare Technologies GEHC News Analytics from Fri, 10 Jan 2025 08:00:00 GMT to Sat, 13 Sep 2025 20:15:49 GMT -
Rating 7
- Innovation 8
- Information 7
- Rumor -3
